World's Best Scientists 2026 revealed!
VIEW LIST
Axel Le Cesne

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 129 2601 2428 69 64 784 60264

Axel Le Cesne publications per year

The chart shows the history of publications by Axel Le Cesne between 1990 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Axel Le Cesne published across 36 years, from 1990 to 2025, averaging 25.1 papers a year. Output peaked at 102 publications in 2023. 32 of the 903 publications appeared in the last two years.

No. of publications
25 50 75 100
Bar chart. Horizontal axis: year, 1990 to 2025. Vertical axis: number of publications, 0 to 102. Peak 102 publications in 2023. 1990: 2 publications 1991: 3 publications 1992: 0 publications 1993: 0 publications 1994: 5 publications 1995: 9 publications 1996: 7 publications 1997: 12 publications 1998: 9 publications 1999: 8 publications 2000: 6 publications 2001: 14 publications 2002: 6 publications 2003: 9 publications 2004: 20 publications 2005: 21 publications 2006: 33 publications 2007: 37 publications 2008: 28 publications 2009: 38 publications 2010: 29 publications 2011: 32 publications 2012: 60 publications 2013: 42 publications 2014: 38 publications 2015: 36 publications 2016: 28 publications 2017: 41 publications 2018: 55 publications 2019: 45 publications 2020: 37 publications 2021: 38 publications 2022: 21 publications 2023: 102 publications 2024: 17 publications 2025: 15 publications
1990 2025

903 publications in total across all disciplines

View publications per year as a table
Axel Le Cesne: publications per year, 1990 to 2025
Year Publications
1990 2
1991 3
1992 0
1993 0
1994 5
1995 9
1996 7
1997 12
1998 9
1999 8
2000 6
2001 14
2002 6
2003 9
2004 20
2005 21
2006 33
2007 37
2008 28
2009 38
2010 29
2011 32
2012 60
2013 42
2014 38
2015 36
2016 28
2017 41
2018 55
2019 45
2020 37
2021 38
2022 21
2023 102
2024 17
2025 15
Total 903
Download as CSV

Axel Le Cesne publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Axel Le Cesne sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 781–800 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 784 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217 784
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Axel Le Cesne D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Axel Le Cesne sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 128–129 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 129 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230 129
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Axel Le Cesne is affiliated with the Institut Gustave Roussy in France and has contributed extensively to the field of medicine, with a focus on oncology and sarcoma research. Their work spans a range of specialized subfields including pulmonary and respiratory medicine, surgery, rheumatology, and gastroenterology.

The primary area of Axel Le Cesne's research concentrates on sarcoma diagnosis and treatment. Additional key topics of their work include vascular tumors and angiosarcomas, gastrointestinal tumor research and treatment, cardiac tumors and thrombi, gastrointestinal disorders and treatments, gastric cancer management and outcomes, and lymphoma diagnosis and treatment.

Their recent notable publications include:

  • Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas, 2020, JAMA
  • Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network, 2021, PLoS ONE
  • Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network, 2020, Annals of Oncology
  • Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, 2020, Cancer

Axel Le Cesne frequently collaborates with several researchers, including:

  • Jean-Yves Blay
  • Nicolas Penel
  • Antoîne Italiano
  • Olivier Mir
  • Emmanuelle Bompas

Their research is often published in journals such as:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • ESMO Open
  • Clinical Cancer Research
  • European Journal of Cancer

Best Publications

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    George D Demetri;Peter Reichardt;Yoon-Koo Kang;Jean-Yves Blay

  • Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

    François Ghiringhelli;Cedric Menard;Pierre Emmanuel Puig;Sylvain Ladoire

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

    Maria Debiec-Rychter;Raf Sciot;Axel Le Cesne;Marcus Schlemmer

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer―Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

    Stefan Sleijfer;Isabelle Ray-Coquard;Zsuzsa Papai;Axel Le Cesne

  • Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

    Patrick Schöffski;Sant Chawla;Robert G. Maki;Antoine Italiano

  • Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

    Isabelle Ray-Coquard;Claire Cropet;Martine Van Glabbeke;Catherine Sebban

  • Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.

    Isabelle Ray-Coquard;Jean-Yves Blay;Antoine Italiano;Axel Le Cesne

  • Cutaneous side-effects of kinase inhibitors and blocking antibodies

    Caroline Robert;Jean-Charles Soria;Alain Spatz;Axel Le Cesne

  • Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

    George D. Demetri;Sant P. Chawla;Margaret von Mehren;Paul Ritch

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control

    Sylvie Bonvalot;Michel Rivoire;Marine Castaing;Eberhard Stoeckle

  • Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.

    J Verweij;A van Oosterom;J.-Y Blay;I Judson

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

    Federica Grosso;Robin L. Jones;George D. Demetri;Ian R. Judson

  • Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

    Penella J. Woll;Peter Reichardt;Axel Le Cesne;Sylvie Bonvalot

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO (vol 16, pg 566, 2005)

    JY Blay;S Bonvalot;P Casali;H Choi

Frequent Co-Authors

Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Antoine Italiano
Antoine Italiano University of Bordeaux
Isabelle Ray-Coquard
Isabelle Ray-Coquard Claude Bernard University Lyon 1
Christine Chevreau
Christine Chevreau DuPont (United States)
François Bertucci
François Bertucci Aix-Marseille University
Paolo G. Casali
Paolo G. Casali University of Milan
Cécile Le Péchoux
Cécile Le Péchoux Institut Gustave Roussy
Jean-Michel Coindre
Jean-Michel Coindre University of Bordeaux
Alessandro Gronchi
Alessandro Gronchi University of Milan
Hans Gelderblom
Hans Gelderblom Leiden University Medical Center

External Links

Personal website of Axel Le Cesne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always require the traditional medical school route. There are numerous alternative pathways and online degrees that offer rewarding roles in the healthcare field, often with less time and financial commitment.

For those interested in patient care but seeking a faster track, adn nursing programs can be an accessible entry point. These programs typically take two years to complete and are often less competitive for admission.

If required entrance exams are a barrier, you may benefit from considering a nursing school that don't require teas or HESI exams. This can open up more opportunities for aspiring nurses.

Not all healthcare careers involve direct patient care. Those interested in the business side of medicine might explore best online medical billing and coding schools, which train students for vital administrative roles.

If leadership interests you, an accelerated healthcare administration degree can help you quickly move into management positions in hospitals, clinics, and other healthcare settings.

Best Scientists Citing Axel Le Cesne

Alessandro Gronchi

Alessandro Gronchi

University of Milan

Publications: 202

Jean-Yves Blay

Jean-Yves Blay

Claude Bernard University Lyon 1

Publications: 176

Paolo G. Casali

Paolo G. Casali

University of Milan

Publications: 130

Antoine Italiano

Antoine Italiano

University of Bordeaux

Publications: 109

Chandrajit P. Raut

Chandrajit P. Raut

Brigham and Women's Hospital

Publications: 106

Peter Hohenberger

Peter Hohenberger

Heidelberg University

Publications: 102

Robert G. Maki

Robert G. Maki

University of Pennsylvania

Publications: 100

Silvia Stacchiotti

Silvia Stacchiotti

University of Milan

Publications: 97

Piotr Rutkowski

Piotr Rutkowski

Maria Sklodowska-Curie National Research Institute of Oncology

Publications: 91

Hans Gelderblom

Hans Gelderblom

Leiden University Medical Center

Publications: 89

Ian Judson

Ian Judson

Institute of Cancer Research

Publications: 88

George D. Demetri

George D. Demetri

Dana-Farber Cancer Institute

Publications: 82

Winette T. A. van der Graaf

Winette T. A. van der Graaf

Erasmus MC

Publications: 80

Guido Kroemer

Guido Kroemer

Université Paris Cité

Publications: 71

Patrick Schöffski

Patrick Schöffski

KU Leuven

Publications: 71

Margaret von Mehren

Margaret von Mehren

Fox Chase Cancer Center

Publications: 70

Trending Scientists

Robert Weiss

Robert Weiss

University of Akron

William G. Fahrenholtz

William G. Fahrenholtz

Missouri University of Science and Technology

Andrej Atrens

Andrej Atrens

University of Queensland

Wendy Hardeman

Wendy Hardeman

University of East Anglia

Carolina de Weerth

Carolina de Weerth

Radboud University

Fabrizio Sassi

Fabrizio Sassi

United States Naval Research Laboratory

Craig A. Townsend

Craig A. Townsend

Johns Hopkins University

Jonathan D. Cooper

Jonathan D. Cooper

Washington University in St. Louis

Robert N. Pike

Robert N. Pike

La Trobe University

Kiaran Kirk

Kiaran Kirk

Australian National University

Antony Bacic

Antony Bacic

La Trobe University

Shimon Slavin

Shimon Slavin

Hebrew University of Jerusalem

Roshini S. Abraham

Roshini S. Abraham

Nationwide Children's Hospital

Hans E. Grossniklaus

Hans E. Grossniklaus

Emory University

Donna M. McDonald-McGinn

Donna M. McDonald-McGinn

Children's Hospital of Philadelphia

Juan Manuel Morales

Juan Manuel Morales

National University of Comahue

Related Medicine Rankings & Guides

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus
2027 Most Affordable Online BSN to DNP Degree Programs

2027 Most Affordable Online BSN to DNP Degree Programs
2027 Most Affordable Online Health Information Management Degree Programs

2027 Most Affordable Online Health Information Management Degree Programs
2026 Easiest Accelerated BSN Programs to Get Into

2026 Easiest Accelerated BSN Programs to Get Into
2027 Most Affordable Online Medical Assistant Programs

2027 Most Affordable Online Medical Assistant Programs
2027 Easiest MPH Online Programs to Get Into

2027 Easiest MPH Online Programs to Get Into
2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus
2027 Best Nursing Schools in Ohio – Accredited ADN, BSN & MSN Programs

2027 Best Nursing Schools in Ohio – Accredited ADN, BSN & MSN Programs
2027 Easiest Nurse Practitioner Degree Programs

2027 Easiest Nurse Practitioner Degree Programs
2027 Most Affordable Online BSN to MSN Bridge Programs

2027 Most Affordable Online BSN to MSN Bridge Programs
2027 Easiest Medical Degree Programs

2027 Easiest Medical Degree Programs
2027 Best Online MSN/MBA Dual Degree Programs

2027 Best Online MSN/MBA Dual Degree Programs
2027 Most Affordable Online FNP Programs

2027 Most Affordable Online FNP Programs
2027 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Maine – Accredited RN to BSN Programs
2027 Best Shortest Online DNP Programs

2027 Best Shortest Online DNP Programs
2027 Best Online DNP Programs Without Clinicals

2027 Best Online DNP Programs Without Clinicals
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus
2027 Fastest Online MSN in Forensic Nursing Programs

2027 Fastest Online MSN in Forensic Nursing Programs
2027 Is Grand Canyon University School of Nursing Worth It?

2027 Is Grand Canyon University School of Nursing Worth It?
2027 Easiest DNP Programs

2027 Easiest DNP Programs
2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus

Recently Published Articles

2027 Fastest-Growing Careers for Political Science Degree Graduates

2027 Fastest-Growing Careers for Political Science Degree Graduates
2027 Is a Master's in Curriculum and Instruction Worth It?

2027 Is a Master's in Curriculum and Instruction Worth It?
2027 Best Accounting Schools in Missouri – How to Become a CPA in MO

2027 Best Accounting Schools in Missouri – How to Become a CPA in MO
2027 What Careers Can You Pursue With a Sports Psychology Degree? Salary Potential, Job Outlook, and Next Steps

2027 What Careers Can You Pursue With a Sports Psychology Degree? Salary Potential, Job Outlook, and Next Steps
2027 Last-Minute Admissions: Online Public Policy Degree Master's Programs Still Accepting Students

2027 Last-Minute Admissions: Online Public Policy Degree Master's Programs Still Accepting Students
2027 Health Administration Degree Careers Ranked by Stress Level, Salary, and Job Stability

2027 Health Administration Degree Careers Ranked by Stress Level, Salary, and Job Stability
2027 Exercise Science vs. Kinesiology Degree: Explaining the Difference

2027 Exercise Science vs. Kinesiology Degree: Explaining the Difference
2027 Addiction Counseling Degree Careers Ranked by Salary, Growth, and Work-Life Balance

2027 Addiction Counseling Degree Careers Ranked by Salary, Growth, and Work-Life Balance
2027 BCBA vs Social Worker: Career Comparison

2027 BCBA vs Social Worker: Career Comparison
2027 Online Music Education Degree Programs Costs: Tuition & Fees

2027 Online Music Education Degree Programs Costs: Tuition & Fees
2027 Fastest Accredited Online School Counseling Programs: Accelerated Degrees and Completion Times

2027 Fastest Accredited Online School Counseling Programs: Accelerated Degrees and Completion Times
2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Business Administration Program?

2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Business Administration Program?
2027 Public Policy Degree Master's Programs with GRE Waivers: Who Qualifies & How to Apply

2027 Public Policy Degree Master's Programs with GRE Waivers: Who Qualifies & How to Apply
2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Clinical Psychology Program?

2027 Which Schools Offer Flexible Start-Anytime Enrollment for a Clinical Psychology Program?
2027 Technical Leadership Roles With the Strongest Promotion Potential

2027 Technical Leadership Roles With the Strongest Promotion Potential
2027 Online Nurse Midwifery Master's Degree Program Costs: Tuition & Fees

2027 Online Nurse Midwifery Master's Degree Program Costs: Tuition & Fees
2027 Christian Counseling Degree Programs With No GRE or GMAT Requirements

2027 Christian Counseling Degree Programs With No GRE or GMAT Requirements
2027 Accounting Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles

2027 Accounting Degree Salary by Experience Level: Entry-Level, Mid-Career, and Senior Roles
2027 Master of Science in Nursing (MSN) Salary

2027 Master of Science in Nursing (MSN) Salary
2027 Pharmacy Degree Programs With Rolling Admissions

2027 Pharmacy Degree Programs With Rolling Admissions
2027 How to Become a Teacher Online in Washington

2027 How to Become a Teacher Online in Washington